RecruitingPHASE1, PHASE2NCT06249919

A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients

Studying Sudden sensorineural hearing loss

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Neuracle Science Co., LTD.
Principal Investigator
Joseph Park, M.D.
Neuracle Science
Intervention
NS101(biological)
Enrollment
138 target
Eligibility
19-70 years · All sexes
Timeline
20242027

Study locations (15)

Collaborators

Samsung Medical Center · Severance Hospital · Korea University Anam Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06249919 on ClinicalTrials.gov

Other trials for Sudden sensorineural hearing loss

Additional recruiting or active studies for the same condition.

See all trials for Sudden sensorineural hearing loss

← Back to all trials